Adma Biologics (ADMA) Current Leases: 2011-2025
Historic Current Leases for Adma Biologics (ADMA) over the last 8 years, with Sep 2025 value amounting to $1.3 million.
- Adma Biologics' Current Leases rose 8.80% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 8.80%. This contributed to the annual value of $1.2 million for FY2024, which is 16.56% up from last year.
- Adma Biologics' Current Leases amounted to $1.3 million in Q3 2025, which was up 15.17% from $1.1 million recorded in Q2 2025.
- Over the past 5 years, Adma Biologics' Current Leases peaked at $1.3 million during Q3 2025, and registered a low of $317,910 during Q1 2021.
- In the last 3 years, Adma Biologics' Current Leases had a median value of $1.1 million in 2025 and averaged $1.1 million.
- Per our database at Business Quant, Adma Biologics' Current Leases skyrocketed by 105.72% in 2022 and then fell by 1.31% in 2025.
- Over the past 5 years, Adma Biologics' Current Leases (Quarterly) stood at $591,084 in 2021, then soared by 53.11% to $905,000 in 2022, then rose by 15.47% to $1.0 million in 2023, then climbed by 16.56% to $1.2 million in 2024, then rose by 8.80% to $1.3 million in 2025.
- Its Current Leases stands at $1.3 million for Q3 2025, versus $1.1 million for Q2 2025 and $1.2 million for Q1 2025.